The Effect of Azithromycin on Relapse in Patients with Moderate-Severe Chronic Graft Versus Host Disease (CGVHD)

被引：0
|
作者：
Shamoun, Mark [1 ]
Braun, Thomas [2 ]
Magenau, John M. [3 ]
Choi, Sung Won [3 ]
Reddy, Pavan [3 ]
Pawarode, Attaphol [3 ]
Riwes, Mary M. [3 ]
Kitko, Carrie L. [4 ]
Anand, Sarah [3 ]
Ghosh, Monalisa [3 ]
Vander Lugt, Mark [3 ]
Bonifant, Challice [3 ]
Abusin, Ghada [3 ]
Parkin, Brian [3 ]
Peltier, Dan [3 ]
Yanik, Gregory A. [3 ]
机构：
[1] Univ Michigan, Pediat, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Publ Hlth, Biostat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Blood & Marrow Transplantat Program, Ann Arbor, MI 48109 USA
[4] Vanderbilt Univ, Med Ctr, Pediat Blood & Marrow Transplantat Program, Nashville, TN USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
33
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD)
    Agha-Hosseini F.
    Mirzaii-Dizgah I.
    Ghavamzadeh L.
    Ghavamzadeh A.
    Tohidast-Acrad Z.
    Bone Marrow Transplantation, 2007, 39 (7) : 431 - 434
  • [42] Oral cGVHD screening tests in the diagnosis of systemic chronic graft-versus-host disease
    Renata Gonçalves Resende
    Jeane de Fátima Correia-Silva
    Telma Cristina Arão
    João Artur Ricieri Brito
    Henrique Bittencourt
    Ricardo Santiago Gomez
    Mauro Henrique Nogueira Guimarães Abreu
    Clinical Oral Investigations, 2012, 16 : 565 - 570
  • [43] Multi-center validation of a prognostic grading in chronic graft versus host disease (cGVHD).
    Akpek, G
    Lee, SJ
    Flowers, MED
    Pavletic, SZ
    Piantadosi, S
    Horowitz, MM
    Antin, JH
    Lynch, JC
    Guthrie, KA
    Takatu, A
    Martin, PJ
    Vogelsang, GB
    BLOOD, 2001, 98 (11) : 740A - 741A
  • [44] Gastrointestinal. involvement in chronic graft versus host disease (cGVHD): A clinicopathologic study.
    Akpek, G
    Chinratanalab, W
    Hallick, JP
    Lee, LA
    Torbenson, M
    Anders, V
    Vogelsang, GB
    BLOOD, 2001, 98 (11) : 396A - 396A
  • [45] Oral tolerance towards pretransplant antigens alleviates chronic graft versus host disease (cGVHD).
    Nagler, A
    Gotsman, I
    Pines, M
    Rabbani, E
    Engelhart, D
    Ilan, Y
    BLOOD, 1999, 94 (10) : 331B - 331B
  • [46] Oral cGVHD screening tests in the diagnosis of systemic chronic graft-versus-host disease
    Resende, Renata Goncalves
    Correia-Silva, Jeane de Fatima
    Arao, Telma Cristina
    Ricieri Brito, Joao Artur
    Bittencourt, Henrique
    Gomez, Ricardo Santiago
    Nogueira Guimaraes Abreu, Mauro Henrique
    CLINICAL ORAL INVESTIGATIONS, 2012, 16 (02) : 565 - 570
  • [47] WEEKLY BORTEZOMIB FOR THE TREATMENT OF STEROID REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD)
    Miller, A. M.
    Schneider, R.
    Agura, E. A.
    Vance, E.
    Bergman, R. B.
    Fay, J.
    Pineiro, L.
    Powell, S.
    Ovcina, Tadic M.
    Sampson, C. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S343 - S343
  • [48] Mycophenolate mofetil (MMF) for the treatment of chronic graft versus host disease (CGVHD) of the liver.
    Roberts, T
    Koc, Y
    Sprague, K
    Grodman, H
    Berkman, E
    Schenkein, D
    Miller, KB
    BLOOD, 1999, 94 (10) : 159A - 159A
  • [49] Adverse Effects of Therapeutic Treatments for Chronic Graft versus Host Disease (cGvHD): Systematic Review
    Dignan, Fiona L.
    Velickovic, Vladica
    McIlwaine, Emily
    Zhang, Rongrong
    Spelman, Tim
    BONE MARROW TRANSPLANTATION, 2018, 53 : 393 - 394
  • [50] PLACENTAL INTRAVENOUS IMMUNOGLOBULIN (PTIVIG) FOR TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD)
    LU, DP
    ZHENG, H
    GUO, NL
    HUANG, XJ
    CHINESE MEDICAL JOURNAL, 1994, 107 (10) : 727 - 727
12345